Fhl1 as a downstream target of Wnt signaling to promote myogenesis of C2C12 cells

Molecular and Cellular Biochemistry

Volumn 365, Issue 1-2, 2012, Pages 251-262

  Lee, Jing Yu ^a   Chien, I Chun ^a   Lin, Win Yu ^a   Wu, Shao Min ^a   Wei, Bo Huei ^a   Lee, Yu En ^a   Lee, Hu Hui ^a  

^a NATIONAL CHIAYI UNIVERSITY   (Taiwan)

Author keywords

Catenin; C2C12; Cell culture; Differentiation; Fhl1; Myogenesis; Wnt signaling

Indexed keywords

BETA CATENIN; WNT PROTEIN;

ANIMAL CELL; ARTICLE; FHL 1 GENE; GENE; GENE EXPRESSION REGULATION; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PROMOTER REGION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIM DOMAIN PROTEINS; LUCIFERASES; MICE; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MYOGENIN; MYOSIN HEAVY CHAINS; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; RNA INTERFERENCE; TRANSCRIPTION, GENETIC; UP-REGULATION; WNT SIGNALING PATHWAY;

MAMMALIA; MURINAE;

EID: 84862808347     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1266-2     Document Type: Article

References (58)

1. G Cossu U Borello 1999 Wnt signaling and the activation of myogenesis in mammals EMBO J 18 6867 6872 10601008 10.1093/emboj/18.24.6867 1:CAS:528:DC%2BD3cXhtFensg%3D%3D
2. S Descamps H Arzouk F Bacou H Bernardi Y Fedon S Gay Y Reyne B Rossano J Levin 2008 Inhibition of myoblast differentiation by Sfrp1 and Sfrp2 Cell Tissue Res 332 299 306 18322704 10.1007/s00441-008-0574-z 1:CAS:528: DC%2BD1cXks1GksL8%3D
3. XH Han YR Jin M Seto JK Yoon 2011 A WNT/beta-catenin signaling activator, R-spondin, plays positive regulatory roles during skeletal myogenesis J Biol Chem 286 10649 10659 21252233 10.1074/jbc.M110.169391 1:CAS:528: DC%2BC3MXjsVyqs7c%3D
4. H Bernardi S Gay Y Fedon B Vernus A Bonnieu F Bacou 2011 Wnt4 activates the canonical β-catenin pathway and regulates negatively myostatin: functional implication in myogenesis Am J Physiol Cell Physiol 300 C1122 C1138 21248078 10.1152/ajpcell.00214.2010 1:CAS:528:DC%2BC3MXmsFClsrg%3D
5. CA Steelman JC Recknor D Nettleton JM Reecy 2006 Transcriptional profiling of myostatin-knockout mice implicates Wnt signaling in postnatal skeletal muscle growth and hypertrophy FASEB J 20 580 582 16423875 1:CAS:528:DC%2BD28Xis12qt7Y%3D
6. S Kuang K Kuroda F Le Grand MA Rudnicki 2007 Asymmetric self-renewal and commitment of satellite stem cells in muscle Cell 129 999 1010 17540178 10.1016/j.cell.2007.03.044 1:CAS:528:DC%2BD2sXmsl2qsbw%3D
7. IM Conboy TA Rando 2002 The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis Dev Cell 3 397 409 12361602 10.1016/S1534-5807(02)00254-X 1:CAS:528: DC%2BD38XntlCqtrY%3D
8. AS Brack IM Conboy MJ Conboy J Shen TA Rando 2008 A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis Cell Stem Cell 2 50 59 18371421 10.1016/j.stem.2007.10.006 1:CAS:528:DC%2BD1cXhtFOlt7g%3D
9. HM Phillips JN Murdoch B Chaudhry AJ Copp DJ Henderson 2005 Vangl2 acts via RhoA signaling to regulate polarized cell movements during development of the proximal outflow tract Circ Res 96 292 299 15637299 10.1161/01.RES. 0000154912.08695.88 1:CAS:528:DC%2BD2MXhtF2ns7Y%3D
10. MP Flaherty A Abdel-Latif Q Li G Hunt S Ranjan Q Ou XL Tang RK Johnson R Bolli B Dawn 2008 Noncanonical Wnt11 signaling is sufficient to induce cardiomyogenic differentiation in unfractionated bone marrow mononuclear cells Circulation 117 2241 2252 18427129 10.1161/CIRCULATIONAHA.107.741066 1:CAS:528:DC%2BD1cXkvFSjtL0%3D
11. M Abdul-Ghani D Dufort R Stiles Y De Repentigny R Kothary LA Megeney 2011 Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals Mol Cell Biol 31 163 178 21041481 10.1128/MCB.01539-09 1:CAS:528:DC%2BC3MXitlCjtr8%3D
12. M Giarré MV Semënov AM Brown 1998 Wnt signaling stabilizes the dual-function protein beta-catenin in diverse cell types Ann N Y Acad Sci 857 43 55 9917831 10.1111/j.1749-6632.1998.tb10106.x
13. IB Dawid JJ Breen R Toyama 1998 LIM domains: multiple roles as adapters and functional modifiers in protein interactions Trends Genet 14 156 162 9594664 10.1016/S0168-9525(98)01424-3 1:CAS:528:DyaK1cXisFOjtLc%3D
14. SM Lee SK Tsui KK Chan M Garcia-Barcelo MM Waye KP Fung CC Liew CY Lee 1998 Chromosomal mapping, tissue distribution and cDNA sequence of four-and-a-half LIM domain protein 1 (FHL1) Gene 216 163 170 9714789 10.1016/S0378-1119(98)00302-3 1:CAS:528:DyaK1cXlvFSisr0%3D
15. MJ McGrath DL Cottle MA Nguyen JM Dyson ID Coghill PA Robinson M Holdsworth BS Cowling EC Hardeman CA Mitchell S Brown 2006 Four and a half LIM protein 1 binds myosin-binding protein C and regulates myosin filament formation and sarcomere assembly J Biol Chem 281 7666 7683 16407297 10.1074/jbc. M512552200 1:CAS:528:DC%2BD28Xit1ygur8%3D
16. MJ McGrath CA Mitchell ID Coghill PA Robinson S Brown 2003 Skeletal muscle LIM protein 1 (SLIM1/FHL1) induces alpha 5 beta -1-integrin-dependent myocyte elongation Am J Physiol Cell Physiol 285 C1513 C1526 12917103 1:CAS:528:DC%2BD2cXhtlSr
17. L Ding Z Wang J Yan X Yang A Liu W Qiu J Zhu J Han H Zhang J Lin L Cheng X Qin C Niu B Yuan X Wang C Zhu Y Zhou J Li H Song C Huang Q Ye 2009 Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway J Clin Invest 119 349 361 19139564 1:CAS:528:DC%2BD1MXhslegsrg%3D
18. J Lin L Ding R Jin H Zhang L Cheng X Qin J Chai Q Ye 2009 Four and a half LIM domains 1 (FHL1) and receptor interacting protein of 140 kDa (RIP140) interact and cooperate in estrogen signaling Int J Biochem Cell Biol 41 1613 1618 19401155 10.1016/j.biocel.2009.02.007 1:CAS:528:DC%2BD1MXktFeru7Y%3D
19. NH Purcell D Darwis OF Bueno JM Müller R Schüle JD Molkentin 2004 Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes Mol Cell Biol 24 1081 1095 14729955 10.1128/MCB.24.3.1081-1095.2004 1:CAS:528:DC%2BD2cXmsFWgtw%3D%3D
20. BS Cowling MJ McGrath MA Nguyen DL Cottle AJ Kee S Brown J Schessl Y Zou J Joya CG Bönnemann EC Hardeman CA Mitchell 2008 Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy J Cell Biol 183 1033 1048 19075112 10.1083/jcb.200804077 1:CAS:528:DC%2BD1cXhsFCqt7vJ
21. J Wang H Qin J Liang Y Zhu L Liang M Zheng H Han 2007 The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation J Mol Biol 370 27 38 17509614 10.1016/j.jmb.2007.04. 010 1:CAS:528:DC%2BD2sXmtVeit7c%3D
22. L Liang HW Zhang J Liang XL Niu SZ Zhang L Feng YM Liang H Han 2008 KyoT3, an isoform of murine FHL1, associates with the transcription factor RBP-J and represses the RBP-J-mediated transactivation Biochim Biophys Acta 1779 805 810 18760388 1:CAS:528:DC%2BD1cXhsVWmtL%2FK
23. F Sheikh A Raskin PH Chu S Lange AA Domenighetti M Zheng X Liang T Zhang T Yajima Y Gu ND Dalton SK Mahata GW Dorn 2nd J Heller-Brown KL Peterson JH Omens AD McCulloch J Chen 2008 An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice J Clin Invest 118 3870 3880 19033658 10.1172/JCI34472 1:CAS:528: DC%2BD1cXhsVKgu73F
24. C Windpassinger B Schoser V Straub S Hochmeister A Noor B Lohberger N Farra E Petek T Schwarzbraun L Ofner WN Löscher K Wagner H Lochmüller JB Vincent S Quasthoff 2008 An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1 Am J Hum Genet 82 88 99 18179888 10.1016/j.ajhg.2007.09.004 1:CAS:528: DC%2BD1cXhsFOks7g%3D
25. B Schoser HH Goebel I Janisch S Quasthoff J Rother M Bergmann W Müller-Felber C Windpassinger 2009 Consequences of mutations within the C terminus of the FHL1 gene Neurology 73 543 551 19687455 10.1212/WNL. 0b013e3181b2a4b3 1:CAS:528:DC%2BD1MXpslOlu7w%3D
26. CM Quinzii TH Vu KC Min K Tanji S Barral RP Grewal A Kattah P Camaño D Otaegui T Kunimatsu DM Blake KC Wilhelmsen LP Rowland AP Hays E Bonilla M Hirano 2008 X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1 Am J Hum Genet 82 208 213 18179901 10.1016/j.ajhg.2007.09.013 1:CAS:528:DC%2BD1cXhsFOksLc%3D
27. DH Chen WH Raskind WW Parson JA Sonnen T Vu Y Zheng M Matsushita J Wolff H Lipe TD Bird 2010 A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutations J Neurol Sci 296 22 29 20633900 10.1016/j.jns.2010.06.017 1:CAS:528:DC%2BC3cXpsFOlt7o%3D
28. J Schessl Y Zou MJ McGrath BS Cowling B Maiti SS Chin C Sewry R Battini Y Hu DL Cottle M Rosenblatt L Spruce A Ganguly J Kirschner AR Judkins JA Golden HH Goebel F Muntoni KM Flanigan CA Mitchell CG Bönnemann 2008 Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy J Clin Invest 118 904 912 18274675 1:CAS:528:DC%2BD1cXivFems74%3D
29. L Gueneau AT Bertrand JP Jais MA Salih T Stojkovic M Wehnert M Hoeltzenbein S Spuler S Saitoh A Verschueren C Tranchant M Beuvin E Lacene NB Romero S Heath D Zelenika T Voit B Eymard R Ben Yaou G Bonne 2009 Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy Am J Hum Genet 85 338 353 19716112 10.1016/j.ajhg.2009.07.015 1:CAS:528:DC%2BD1MXhsVChsL7I
30. M Fryknäs U Wickenberg-Bolin H Göransson MG Gustafsson T Foukakis JJ Lee U Landegren A Höög C Larsson L Grimelius G Wallin U Pettersson A Isaksson 2006 Molecular markers for discrimination of benign and malignant follicular thyroid tumors Tumour Biol 27 211 220 16675914 10.1159/000093056
31. X Li Z Jia Y Shen H Ichikawa J Jarvik RG Nagele GS Goldberg 2008 Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate Cancer Sci 99 1326 1333 18422756 10.1111/j.1349-7006.2008. 00816.x 1:CAS:528:DC%2BD1cXot1eitrk%3D
32. K Sakashita K Mimori F Tanaka Y Kamohara H Inoue T Sawada K Hirakawa M Mori 2008 Clinical significance of loss of Fhl1 expression in human gastric cancer Ann Surg Oncol 15 2293 2300 18465173 10.1245/s10434-008-9904-3
33. M Matsumoto K Kawakami H Enokida K Toki R Matsuda T Chiyomaru K Nishiyama K Kawahara N Seki M Nakagawa 2010 CpG hypermethylation of human four-and-a-half LIM domains 1 contributes to migration and invasion activity of human bladder cancer Int J Mol Med 26 241 247 20596604 1:CAS:528:DC%2BC3cXhtVGlu7zK
34. C Niu C Liang J Guo L Cheng H Zhang X Qin Q Zhang L Ding B Yuan X Xu J Li J Lin Q Ye 2011 Downregulation and growth inhibitory role of FHL1 in lung cancer Int J Cancer 10.1002/ijc.26259 [Epub ahead of print]
35. Y Shen Z Jia RG Nagele H Ichikawa GS Goldberg 2006 SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells Cancer Res 66 1543 1552 16452211 10.1158/0008-5472.CAN-05-3152 1:CAS:528:DC%2BD28XpsVeguw%3D%3D
36. P Chomczynski N Sacchi 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 156 159 2440339 10.1016/0003-2697(87)90021-2 1:CAS:528:DyaL2sXitFSns7Y%3D
37. PW Laird A Zijderveld K Linders MA Rudnicki R Jaenisch A Berns 1991 Simplified mammalian DNA isolation procedure Nucleic Acids Res 19 4293 1870982 10.1093/nar/19.15.4293 1:CAS:528:DyaK3MXlslKltb0%3D
38. O Landt HP Grunert U Hahn 1990 A general method for rapid site-directed mutagenesis using the polymerase chain reaction Gene 96 125 128 2265750 10.1016/0378-1119(90)90351-Q 1:CAS:528:DyaK3MXksVensrw%3D
39. Q Eastman R Grosschedl 1999 Regulation of LEF-1/TCF transcription factors by Wnt and other signals Curr Opin Cell Biol 11 233 240 10209158 10.1016/S0955-0674(99)80031-3 1:CAS:528:DyaK1MXisFWlsbo%3D
40. R van Amerongen R Nusse 2009 Towards an integrated view of Wnt signaling in development Development 136 3205 3214 19736321 10.1242/dev.033910
41. P Bernard VR Harley 2007 Wnt4 action in gonadal development and sex determination Int J Biochem Cell Biol 39 31 43 16905353 10.1016/j.biocel.2006. 06.007 1:CAS:528:DC%2BD28XhtVygt7%2FE
42. MV Chang JL Chang A Gangopadhyay A Shearer KM Cadigan 2008 Activation of wingless targets requires bipartite recognition of DNA by TCF Curr Biol 18 1877 1881 19062282 10.1016/j.cub.2008.10.047 1:CAS:528:DC%2BD1cXhsVOju7zE
43. EL Huguet JA McMahon AP McMahon R Bicknell AL Harris 1994 Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue Cancer Res 54 2615 2621 8168088 1:CAS:528:DyaK2cXkt1ynsbc%3D
44. T Akimoto T Ushida S Miyaki H Akaogi K Tsuchiya Z Yan RS Williams T Tateishi 2005 Mechanical stretch inhibits myoblast-to-adipocyte differentiation through Wnt signaling Biochem Biophys Res Commun 329 381 385 15721317 10.1016/j.bbrc.2005.01.136 1:CAS:528:DC%2BD2MXhsFSisb0%3D
45. A Nakashima T Katagiri M Tamura 2005 Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts J Biol Chem 280 37660 37668 16150699 10.1074/jbc.M504612200 1:CAS:528:DC%2BD2MXhtF2isrnL
46. H Takata K Terada H Oka Y Sunada T Moriguchi T Nohno 2007 Involvement of Wnt4 signaling during myogenic proliferation and differentiation of skeletal muscle Dev Dyn 236 2800 2807 17879321 10.1002/dvdy.21327 1:CAS:528: DC%2BD2sXhtlelsrfL
47. T Honda H Yamamoto A Ishii M Inui 2010 PDZRN3 negatively regulates BMP-2-induced osteoblast differentiation through inhibition of Wnt signaling Mol Biol Cell 21 3269 3277 20668165 10.1091/mbc.E10-02-0117 1:CAS:528: DC%2BC3cXhtlGlt7vI
48. MJ Morgan AJ Madgwick 1999 The LIM proteins FHL1 and FHL3 are expressed differently in skeletal muscle Biochem Biophys Res Commun 255 245 250 10049693 10.1006/bbrc.1999.0179 1:CAS:528:DyaK1MXhsVShsrk%3D
49. JJ Love X Li DA Case K Giese R Grosschedl PE Wright 1995 Structural basis for DNA bending by the architectural transcription factor LEF-1 Nature 376 791 795 7651541 10.1038/376791a0 1:CAS:528:DyaK2MXnvFChsLs%3D
50. S Tanaka K Terada T Nohno 2011 Canonical Wnt signaling is involved in switching from cell proliferation to myogenic differentiation of mouse myoblast cells J Mol Signaling 6 12 10.1186/1750-2187-6-12 1:CAS:528:DC%2BC3MXhs1Khu77P
51. J Chang W Sonoyama Z Wang Q Jin C Zhang PH Krebsbach W Giannobile S Shi CY Wang 2008 Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK J Biol Chem 282 30938 30948 10.1074/jbc.M702391200
52. G Xiang Q Yang B Wang N Sekiya X Mu Y Tang CW Chen M Okada J Cummins B Gharaibeh J Huard 2011 Lentivirus-mediated Wnt11 gene transfer enhances cardiomyogenic differentiation of skeletal muscle-derived stem cells Mol Ther 19 790 796 21304494 10.1038/mt.2011.5 1:CAS:528:DC%2BC3MXhs1Snt7s%3D
53. M Aragaki K Tsuchiya R Okamoto S Yoshioka T Nakamura N Sakamoto T Kanai M Watanabe 2008 Proteasomal degradation of Atoh1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer Biochem Biophys Res Commun 368 923 929 18275842 10.1016/j.bbrc.2008.02.011 1:CAS:528:DC%2BD1cXjtVKltLo%3D
54. M Suzuki H Shigematsu T Nakajima R Kubo S Motohashi Y Sekine K Shibuya T Iizasa K Hiroshima Y Nakatani AF Gazdar T Fujisawa 2007 Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non small cell lung cancer Clin Cancer Res 13 6087 6092 17947472 10.1158/1078-0432.CCR-07-0591 1:CAS:528:DC%2BD2sXhtFygs7bJ
55. CH Zhao XM Bu N Zhang 2007 Hypermethylation and aberrant expression of Wnt antagonist secreted frizzled-related protein 1 in gastric cancer World J Gastroenterol 13 2214 2217 17465504 10.3748/wjg.13.6558 1:CAS:528: DC%2BD2sXmvFGrtbY%3D
56. MV Hadjihannas M Brückner B Jerchow W Birchmeier W Dietmaier J Behrens 2006 Aberrant Wnt/beta-catenin signaling can induce chromosomal instability in colon cancer Proc Natl Acad Sci U S A 103 10747 10752 16815967 10.1073/pnas.0604206103 1:CAS:528:DC%2BD28XntFWmsbs%3D
57. J Veeck D Niederacher H An E Klopocki F Wiesmann B Betz O Galm O Camara M Dürst G Kristiansen C Huszka R Knüchel E Dahl 2006 Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis Oncogene 25 3479 3488 16449975 10.1038/sj.onc.1209386 1:CAS:528:DC%2BD28XlsVersbw%3D
58. S Urakami H Shiina H Enokida T Kawakami T Tokizane T Ogishima Y Tanaka LC Li LA Ribeiro-Filho M Terashima N Kikuno H Adachi T Yoneda H Kishi K Shigeno BR Konety M Igawa R Dahiya 2006 Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway Clin Cancer Res 12 383 391 16428476 10.1158/1078-0432.CCR-05-1344 1:CAS:528:DC%2BD28XmtlKjsA%3D%3D